AA
Atul Agrawal
About Atul Agrawal
Data last updated:
Atul Agrawal is a Director at Swaroop Pharmaceuticals Private Limited (since 2008), Director at Man Safe Health Care Devices Private Limited (since 2013) and Director at Subh Parenteral Private Limited (since 2021). The companies operate in Pharma, Chemicals and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹82.30 Cr; the largest is Swaroop Pharmaceuticals Private Limited at ₹82.25 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Swaroop Pharmaceuticals Private Limited U24231UP1998PTC023440 | Director | 31 Mar 2008 | 1998 | ₹82.25 Cr (FY 2022) | Active |
 Man Safe Health Care Devices Private Limited U85100UP2008PTC036035 | Director | 31 Oct 2013 | 2008 | ₹4.2 Lakh (FY 2025) | Active |
| Subh Parenteral Private Limited U24233UP2021PTC141159 | Director | 03 Feb 2021 | 2021 | ₹77,178 (FY 2023) | Active |
Board colleagues of Atul Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jaiprakash Agarwal | 02156873 | Swaroop Pharmaceuticals Private Limited | Director |
| Puneet Kela | 01222021 | Swaroop Pharmaceuticals Private Limited | Director |
| Sanjay Maheshwari | 00517385 | Swaroop Pharmaceuticals Private Limited , Subh Parenteral Private Limited | Director |
| Vijay Maheshwari | 02150226 | Swaroop Pharmaceuticals Private Limited , Man Safe Health Care Devices Private Limited | Director |
| Vineet Kela | 01042495 | Swaroop Pharmaceuticals Private Limited , Man Safe Health Care Devices Private Limited and 1 more | Director |
| Arun Singh | 09032561 | Subh Parenteral Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Atul Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atul Agrawal
Atul Agrawal currently holds 3 directorships: Swaroop Pharmaceuticals Private Limited (Director, since 31 Mar 2008, revenue ₹82.25 Cr (FY 2022)); Man Safe Health Care Devices Private Limited (Director, since 31 Oct 2013, revenue ₹4.2 Lakh (FY 2025)); Subh Parenteral Private Limited (Director, since 03 Feb 2021, revenue ₹77,178 (FY 2023)).
Atul Agrawal was first appointed on 31 Mar 2008 as Director at Swaroop Pharmaceuticals Private Limited. The most recent appointment on record is 03 Feb 2021 at Subh Parenteral Private Limited.
The 3 current companies of Atul Agrawal that report revenue have a combined latest revenue of ₹82.30 Cr: Swaroop Pharmaceuticals Private Limited ₹82.25 Cr (FY 2022); Man Safe Health Care Devices Private Limited ₹4.2 Lakh (FY 2025); Subh Parenteral Private Limited ₹77,178 (FY 2023).
The current boards of Atul Agrawal's companies include Jaiprakash Agarwal (Swaroop Pharmaceuticals Private Limited), Puneet Kela (Swaroop Pharmaceuticals Private Limited), Sanjay Maheshwari (Swaroop Pharmaceuticals Private Limited), Vijay Maheshwari (Swaroop Pharmaceuticals Private Limited), Vineet Kela (Swaroop Pharmaceuticals Private Limited), Arun Singh (Subh Parenteral Private Limited).